CASI Annual SG&A
$41.84 M
+$4.06 M+10.75%
31 December 2023
Summary:
As of January 22, 2025, CASI annual selling, general & administrative expenses is $41.84 million, with the most recent change of +$4.06 million (+10.75%) on December 31, 2023. During the last 3 years, it has risen by +$14.36 million (+52.27%). CASI annual SG&A is now at all-time high.CASI Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Quarterly SG&A
$10.61 M
+$242.00 K+2.33%
01 September 2024
Summary:
As of January 22, 2025, CASI quarterly selling, general & administrative expenses is $10.61 million, with the most recent change of +$242.00 thousand (+2.33%) on September 1, 2024. Over the past year, it has dropped by -$961.00 thousand (-8.31%). CASI quarterly SG&A is now -16.13% below its all-time high of $12.65 million, reached on December 31, 2021.CASI Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI TTM SG&A
-$2.69 B
-$30.04 M-1.13%
01 September 2024
Summary:
As of January 22, 2025, CASI TTM selling, general & administrative expenses is -$2.69 billion, with the most recent change of -$30.04 million (-1.13%) on September 1, 2024. Over the past year, it has dropped by -$2.74 billion (-6539.70%). CASI TTM SG&A is now -12035.93% below its all-time high of $42.48 million, reached on June 30, 2023.CASI TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.8% | -8.3% | -6539.7% |
| 3 y3 years | +52.3% | -8.3% | -6539.7% |
| 5 y5 years | +132.5% | -8.3% | -6539.7% |
CASI Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +10.8% | -16.1% | +32.0% | -13.2% | at low |
| 5 y | 5-year | at high | +52.3% | -16.1% | +99.5% | -33.0% | at low |
| alltime | all time | at high | +1395.3% | -16.1% | +1932.8% | <-9999.0% | at low |
CASI Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.61 M(+2.3%) | $41.09 M(+6.7%) |
| June 2024 | - | $10.37 M(+21.3%) | $38.52 M(-5.3%) |
| Mar 2024 | - | $8.55 M(-26.1%) | $40.68 M(-2.8%) |
| Dec 2023 | $41.84 M(+10.8%) | $11.57 M(+43.9%) | $41.84 M(-0.6%) |
| Sept 2023 | - | $8.04 M(-35.8%) | $42.11 M(-0.9%) |
| June 2023 | - | $12.52 M(+29.0%) | $42.48 M(+9.3%) |
| Mar 2023 | - | $9.71 M(-18.0%) | $38.88 M(+2.9%) |
| Dec 2022 | $37.77 M(-1.6%) | $11.84 M(+40.7%) | $37.77 M(-2.1%) |
| Sept 2022 | - | $8.41 M(-5.6%) | $38.58 M(-0.7%) |
| June 2022 | - | $8.92 M(+3.7%) | $38.86 M(+0.2%) |
| Mar 2022 | - | $8.60 M(-32.0%) | $38.79 M(+1.0%) |
| Dec 2021 | $38.41 M(+39.8%) | $12.65 M(+45.5%) | $38.41 M(+10.2%) |
| Sept 2021 | - | $8.69 M(-1.8%) | $34.86 M(+3.8%) |
| June 2021 | - | $8.85 M(+7.7%) | $33.58 M(+10.6%) |
| Mar 2021 | - | $8.22 M(-9.8%) | $30.38 M(+10.6%) |
| Dec 2020 | $27.48 M(-9.7%) | $9.11 M(+22.9%) | $27.48 M(+1.1%) |
| Sept 2020 | - | $7.41 M(+31.3%) | $27.16 M(-5.4%) |
| June 2020 | - | $5.64 M(+6.1%) | $28.71 M(-4.5%) |
| Mar 2020 | - | $5.32 M(-39.5%) | $30.05 M(-1.3%) |
| Dec 2019 | $30.44 M(+69.1%) | $8.79 M(-1.8%) | $30.44 M(+11.1%) |
| Sept 2019 | - | $8.95 M(+28.2%) | $27.39 M(+8.1%) |
| June 2019 | - | $6.98 M(+22.3%) | $25.34 M(+13.1%) |
| Mar 2019 | - | $5.71 M(-0.6%) | $22.40 M(+24.5%) |
| Dec 2018 | $18.00 M(+470.2%) | $5.75 M(-16.8%) | $18.00 M(+33.9%) |
| Sept 2018 | - | $6.91 M(+70.8%) | $13.45 M(+87.6%) |
| June 2018 | - | $4.04 M(+210.2%) | $7.17 M(+87.8%) |
| Mar 2018 | - | $1.30 M(+9.1%) | $3.82 M(+20.9%) |
| Dec 2017 | $3.16 M(-33.9%) | $1.19 M(+90.9%) | $3.16 M(-6.6%) |
| Sept 2017 | - | $625.90 K(-9.5%) | $3.38 M(-1.5%) |
| June 2017 | - | $691.40 K(+7.3%) | $3.43 M(-26.3%) |
| Mar 2017 | - | $644.20 K(-54.6%) | $4.65 M(-2.5%) |
| Dec 2016 | $4.78 M(+53.1%) | $1.42 M(+109.5%) | $4.78 M(+18.9%) |
| Sept 2016 | - | $676.90 K(-64.6%) | $4.02 M(+0.1%) |
| June 2016 | - | $1.91 M(+150.3%) | $4.01 M(+35.8%) |
| Mar 2016 | - | $765.10 K(+16.1%) | $2.96 M(-5.1%) |
| Dec 2015 | $3.12 M(-17.0%) | $659.20 K(-2.2%) | $3.12 M(-5.0%) |
| Sept 2015 | - | $673.90 K(-21.4%) | $3.28 M(-12.7%) |
| June 2015 | - | $857.60 K(-7.3%) | $3.76 M(-0.9%) |
| Mar 2015 | - | $924.80 K(+12.4%) | $3.79 M(+0.9%) |
| Dec 2014 | $3.76 M(+22.6%) | $823.10 K(-28.4%) | $3.76 M(+3.1%) |
| Sept 2014 | - | $1.15 M(+29.0%) | $3.64 M(+15.4%) |
| June 2014 | - | $891.90 K(+0.1%) | $3.16 M(-3.8%) |
| Mar 2014 | - | $891.40 K(+25.3%) | $3.28 M(+8.7%) |
| Dec 2013 | $3.06 M(+9.5%) | $711.20 K(+7.3%) | $3.02 M(+6.2%) |
| Sept 2013 | - | $662.60 K(-34.8%) | $2.84 M(+3.6%) |
| June 2013 | - | $1.02 M(+61.2%) | $2.75 M(+17.8%) |
| Mar 2013 | - | $629.90 K(+17.7%) | $2.33 M(-16.7%) |
| Dec 2012 | $2.80 M(-8.3%) | $535.10 K(-5.2%) | $2.80 M(+0.5%) |
| Sept 2012 | - | $564.60 K(-6.1%) | $2.78 M(+0.3%) |
| June 2012 | - | $601.50 K(-45.2%) | $2.78 M(-4.1%) |
| Mar 2012 | - | $1.10 M(+110.1%) | $2.90 M(-5.1%) |
| Dec 2011 | $3.05 M(-10.2%) | $521.90 K(-6.2%) | $3.05 M(-10.6%) |
| Sept 2011 | - | $556.60 K(-22.7%) | $3.41 M(-3.8%) |
| June 2011 | - | $719.90 K(-42.6%) | $3.55 M(-1.4%) |
| Mar 2011 | - | $1.25 M(+41.7%) | $3.60 M(+5.9%) |
| Dec 2010 | $3.40 M | $884.30 K(+27.9%) | $3.40 M(-3.9%) |
| Sept 2010 | - | $691.60 K(-10.3%) | $3.54 M(-5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | $770.70 K(-26.7%) | $3.76 M(-6.0%) |
| Mar 2010 | - | $1.05 M(+2.9%) | $4.00 M(-2.6%) |
| Dec 2009 | $4.10 M(-47.1%) | $1.02 M(+12.1%) | $4.10 M(-26.3%) |
| Sept 2009 | - | $911.80 K(-9.8%) | $5.57 M(-10.3%) |
| June 2009 | - | $1.01 M(-12.8%) | $6.21 M(-10.5%) |
| Mar 2009 | - | $1.16 M(-53.4%) | $6.94 M(-10.6%) |
| Dec 2008 | $7.76 M(+5.1%) | $2.49 M(+60.4%) | $7.76 M(+7.0%) |
| Sept 2008 | - | $1.55 M(-10.8%) | $7.25 M(-2.1%) |
| June 2008 | - | $1.74 M(-12.3%) | $7.41 M(-1.7%) |
| Mar 2008 | - | $1.98 M(+0.2%) | $7.54 M(+2.1%) |
| Dec 2007 | $7.39 M(-0.1%) | $1.98 M(+16.0%) | $7.39 M(-2.1%) |
| Sept 2007 | - | $1.71 M(-8.7%) | $7.54 M(+2.8%) |
| June 2007 | - | $1.87 M(+2.1%) | $7.34 M(-1.0%) |
| Mar 2007 | - | $1.83 M(-14.3%) | $7.41 M(+0.2%) |
| Dec 2006 | $7.39 M(+24.9%) | $2.14 M(+42.7%) | $7.39 M(+8.9%) |
| Sept 2006 | - | $1.50 M(-22.9%) | $6.79 M(-4.1%) |
| June 2006 | - | $1.94 M(+6.9%) | $7.08 M(+9.3%) |
| Mar 2006 | - | $1.82 M(+18.5%) | $6.48 M(+9.4%) |
| Dec 2005 | $5.92 M(-9.9%) | $1.53 M(-14.2%) | $5.92 M(+6.4%) |
| Sept 2005 | - | $1.79 M(+33.4%) | $5.56 M(+8.8%) |
| June 2005 | - | $1.34 M(+6.2%) | $5.11 M(-10.9%) |
| Mar 2005 | - | $1.26 M(+7.2%) | $5.74 M(-12.7%) |
| Dec 2004 | $6.57 M(-6.4%) | $1.18 M(-12.1%) | $6.57 M(-10.8%) |
| Sept 2004 | - | $1.34 M(-31.9%) | $7.37 M(-5.3%) |
| June 2004 | - | $1.96 M(-6.2%) | $7.78 M(+3.9%) |
| Mar 2004 | - | $2.09 M(+6.1%) | $7.49 M(+6.6%) |
| Dec 2003 | $7.02 M(-49.6%) | $1.97 M(+12.9%) | $7.02 M(-9.8%) |
| Sept 2003 | - | $1.75 M(+4.4%) | $7.78 M(-15.4%) |
| June 2003 | - | $1.67 M(+2.9%) | $9.20 M(-21.8%) |
| Mar 2003 | - | $1.63 M(-40.5%) | $11.77 M(-15.5%) |
| Dec 2002 | $13.93 M(-11.9%) | $2.73 M(-13.8%) | $13.93 M(-12.7%) |
| Sept 2002 | - | $3.17 M(-25.2%) | $15.96 M(-4.4%) |
| June 2002 | - | $4.24 M(+11.8%) | $16.69 M(+1.9%) |
| Mar 2002 | - | $3.79 M(-20.3%) | $16.37 M(+3.5%) |
| Dec 2001 | $15.82 M(+24.8%) | $4.76 M(+22.0%) | $15.82 M(+5.7%) |
| Sept 2001 | - | $3.90 M(-0.6%) | $14.96 M(+7.4%) |
| June 2001 | - | $3.92 M(+21.3%) | $13.93 M(+5.5%) |
| Mar 2001 | - | $3.23 M(-17.1%) | $13.21 M(+4.2%) |
| Dec 2000 | $12.67 M(+58.4%) | $3.90 M(+35.8%) | $12.67 M(+18.8%) |
| Sept 2000 | - | $2.87 M(-10.3%) | $10.67 M(+6.7%) |
| June 2000 | - | $3.20 M(+18.7%) | $10.00 M(+13.6%) |
| Mar 2000 | - | $2.70 M(+41.9%) | $8.80 M(+10.0%) |
| Dec 1999 | $8.00 M(+37.9%) | $1.90 M(-13.6%) | $8.00 M(0.0%) |
| Sept 1999 | - | $2.20 M(+9.8%) | $8.00 M(+11.1%) |
| June 1999 | - | $2.00 M(+5.7%) | $7.20 M(+12.6%) |
| Mar 1999 | - | $1.90 M(-0.2%) | $6.40 M(+10.3%) |
| Dec 1998 | $5.80 M(+18.4%) | $1.90 M(+35.7%) | $5.80 M(-1.7%) |
| Sept 1998 | - | $1.40 M(+16.7%) | $5.90 M(+9.3%) |
| June 1998 | - | $1.20 M(-7.7%) | $5.40 M(0.0%) |
| Mar 1998 | - | $1.30 M(-35.0%) | $5.40 M(+12.5%) |
| Dec 1997 | $4.90 M(+44.1%) | $2.00 M(+122.2%) | $4.80 M(+14.3%) |
| Sept 1997 | - | $900.00 K(-25.0%) | $4.20 M(+5.0%) |
| June 1997 | - | $1.20 M(+71.4%) | $4.00 M(-11.1%) |
| Mar 1997 | - | $700.00 K(-50.0%) | $4.50 M(-31.8%) |
| Dec 1996 | $3.40 M | $1.40 M(+100.0%) | $6.60 M(+26.9%) |
| Sept 1996 | - | $700.00 K(-58.8%) | $5.20 M(+15.6%) |
| June 1996 | - | $1.70 M(-39.3%) | $4.50 M(+60.7%) |
| Mar 1996 | - | $2.80 M | $2.80 M |
FAQ
- What is CASI Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual SG&A year-on-year change?
- What is CASI Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly SG&A year-on-year change?
- What is CASI Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals TTM SG&A year-on-year change?
What is CASI Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of CASI is $41.84 M
What is the all time high annual SG&A for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual selling, general & administrative expenses is $41.84 M
What is CASI Pharmaceuticals annual SG&A year-on-year change?
Over the past year, CASI annual selling, general & administrative expenses has changed by +$4.06 M (+10.75%)
What is CASI Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of CASI is $10.61 M
What is the all time high quarterly SG&A for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $12.65 M
What is CASI Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, CASI quarterly selling, general & administrative expenses has changed by -$961.00 K (-8.31%)
What is CASI Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of CASI is -$2.69 B
What is the all time high TTM SG&A for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high TTM selling, general & administrative expenses is $42.48 M
What is CASI Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, CASI TTM selling, general & administrative expenses has changed by -$2.74 B (-6539.70%)